Accelerated Discovery of Cryoprotectant Cocktails via Multi-Objective Bayesian Optimization

📅 2026-02-13
📈 Citations: 0
Influential: 0
📄 PDF

career value

225K/year
🤖 AI Summary
This work addresses the challenge of designing cryoprotectant agent (CPA) formulations, which requires balancing ice inhibition against cellular viability—a trade-off traditionally explored through inefficient empirical or exhaustive experimental approaches. The study introduces, for the first time, a multi-objective Bayesian optimization framework integrated with active learning to navigate this complex design space. By coupling high-throughput screening with probabilistic surrogate models and iteratively selecting high-potential experiments via the Expected Pareto Improvement (EPI) acquisition strategy, the method efficiently explores formulation landscapes. It significantly enhances Pareto front quality, achieving equivalent or superior performance to prior state-of-the-art results using only 30% of the experimental budget in synthetic benchmarks. The approach demonstrates a 9.5% and 4.5% improvement in dominated hypervolume, reduces experimental time by approximately ten weeks, and exhibits robust generalizability across diverse cell lines and CPA libraries.

Technology Category

Application Category

📝 Abstract
Designing cryoprotectant agent (CPA) cocktails for vitrification is challenging because formulations must be concentrated enough to suppress ice formation yet non-toxic enough to preserve cell viability. This tradeoff creates a large, multi-objective design space in which traditional discovery is slow, often relying on expert intuition or exhaustive experimentation. We present a data-efficient framework that accelerates CPA cocktail design by combining high-throughput screening with an active-learning loop based on multi-objective Bayesian optimization. From an initial set of measured cocktails, we train probabilistic surrogate models to predict concentration and viability and quantify uncertainty across candidate formulations. We then iteratively select the next experiments by prioritizing cocktails expected to improve the Pareto front, maximizing expected Pareto improvement under uncertainty, and update the models as new assay results are collected. Wet-lab validation shows that our approach efficiently discovers cocktails that simultaneously achieve high CPA concentrations and high post-exposure viability. Relative to a naive strategy and a strong baseline, our method improves dominated hypervolume by 9.5\% and 4.5\%, respectively, while reducing the number of experiments needed to reach high-quality solutions. In complementary synthetic studies, it recovers a comparably strong set of Pareto-optimal solutions using only 30\% of the evaluations required by the prior state-of-the-art multi-objective approach, which amounts to saving approximately 10 weeks of experimental time. Because the framework assumes only a suitable assay and defined formulation space, it can be adapted to different CPA libraries, objective definitions, and cell lines to accelerate cryopreservation development.
Problem

Research questions and friction points this paper is trying to address.

cryoprotectant cocktails
vitrification
multi-objective optimization
cell viability
ice formation
Innovation

Methods, ideas, or system contributions that make the work stand out.

multi-objective Bayesian optimization
cryoprotectant cocktails
Pareto front
active learning
high-throughput screening
💼 Related Jobs
Postdoctoral Fellow – AI/ML Enabled Bioprocess Modeling and Control
Pfizer
The annual base salary for this position ranges from $64,600.00 to $107,600.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 7.5% of the base salary. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States. Relocation assistance may be available based on business needs and/or eligibility.
United States - Massachusetts - Andover
D
Daniel Emerson
Mechanical Engineering Department, Carnegie Mellon University, Pittsburgh PA USA
N
Nora Gaby-Biegel
Center for Engineering in Medicine & Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, and Shriners Children’s, Boston MA USA
P
Purva Joshi
Center for Engineering in Medicine & Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, and Shriners Children’s, Boston MA USA
Y
Yoed Rabin
Mechanical Engineering Department, Carnegie Mellon University, Pittsburgh PA USA
R
Rebecca D. Sandlin
Center for Engineering in Medicine & Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, and Shriners Children’s, Boston MA USA
Levent Burak Kara
Levent Burak Kara
Carnegie Mellon University
Computer Aided DesignComputer GraphicsMechanical EngineeringMachine LearningArtificial